Product Information

AMIODARONE HCL 400 MG TABLET is a generic product labeled by Advagen Pharma Ltd., priced at $0.7431 per EA under NDC 72888006130. Its NADAC has been published 272 times since Sep 8, 2021.

FDA first approved this application on Nov 6, 2008. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

AMIODARONE HCL 400 MG TABLET

Amiodarone Hydrochloride
$0.7431per EA

Strength

400 mg/1

NDC

72888006130

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

AMIODARONE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA078578

FDA Approved

11/6/2008

TE Code

AB

On Market Since

8/21/2020

Pharmacological Classes

Antiarrhythmic
Cytochrome P450 1A2 Inhibitors
Cytochrome P450 2C9 Inhibitors
Cytochrome P450 2D6 Inhibitors
Cytochrome P450 3A Inhibitors
P-Glycoprotein Inhibitors

Price Statistics

The NADAC for AMIODARONE HCL 400 MG TABLET has been published 272 times since Sep 8, 2021, and over the history we have for it it has declined 56.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.7431 per EA
All-time high$3.0563 (Apr 13, 2022)
All-time low$0.2214 (Aug 21, 2024)
52-week high$0.7431
52-week low$0.3410
Median price$0.6456
Average price$1.0094
Largest weekly change-74.0% (Mar 20, 2024)
Weeks tracked272
Tracking sinceSep 8, 2021

Price History

1W

+15.1%

1M

+48.8%

3M

+88.7%

6M

+98.4%

1Y

+93.7%

3Y

-53.7%

5Y

-68.8%

All

-56.9%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of AMIODARONE HCL 400 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for AMIODARONE HCL 400 MG TABLET, manufactured by Advagen Pharma Ltd., is $0.7431 per EA (NDC 72888006130), effective Nov 18, 2026.

How has the price of AMIODARONE HCL 400 MG TABLET changed over time?

Over the history we have for it, the NADAC for AMIODARONE HCL 400 MG TABLET has declined 56.9%. It has been tracked across 272 weekly CMS publications since Sep 8, 2021.

What are the highest and lowest recorded NADAC prices for AMIODARONE HCL 400 MG TABLET?

Since Sep 8, 2021, the NADAC for AMIODARONE HCL 400 MG TABLET has ranged from a low of $0.2214 (Aug 21, 2024) to a high of $3.0563 (Apr 13, 2022), with a median of $0.6456 per EA.

Are there cheaper alternatives to AMIODARONE HCL 400 MG TABLET?

Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PACERONE 400 MG TABLET, is $0.7188 per EA — about 3% below AMIODARONE HCL 400 MG TABLET.

Who manufactures AMIODARONE HCL 400 MG TABLET?

AMIODARONE HCL 400 MG TABLET (NDC 72888006130) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.